# Japanese Phase 1 Study of BMS-844203 (CT322)

> **NCT01146171** · PHASE1 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BMS-844203 (CT-322)

## Key facts

- **NCT ID:** NCT01146171
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146171, "Japanese Phase 1 Study of BMS-844203 (CT322)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01146171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*